BioSpace News Archive

Lyra Therapeutics, Inc. announced that Maria Palasis, Ph.D., Lyra’s President and Chief Executive Officer, will participate in a fireside chat at the William Blair 41st Annual Growth Stock Conference on Thursday, June 3, 2021 at 11:30am EDT.

Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, announced that the U.S. Food and Drug Administration is “on site” for the ROLONTIS® manufacturing facility inspection.

Learnings to be Presented by Carlos Moraes, Ph.D., from University of Miami at UMDF’s Mitochondrial Medicine Symposium on June 4, 2021

Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka Endocan Corporation. (WKN:A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is proud to announce it has officially received OTC Markets registration confirmations, completing its new OTC Markets registration ready to upload all newly updated State of Nevada registered corporate information.

Biogen Inc. (Nasdaq: BIIB) and Bio-Thera Solutions, Ltd. (688177.SH) today announced results from the Phase 3 study of BAT1806, a proposed biosimilar referencing ACTEMRA ® /RoACTEMRA ® (tocilizumab). The study met its primary endpoints, demonstrating equivalence to the reference medicine in patients with moderate to severe rheumatoid arthritis (RA) inadequately controlled by methotrexate therapy.

- Zai Lab obtains the right to develop and exclusively commercialize adagrasib in China, Hong Kong, Macau and Taiwan - Mirati to receive an upfront payment of $65 million, up to approximately $273 million in potential milestone payments and high-teen- to low-twenties-percent tiered royalties - Agreement will accelerate enrollment in key global, registration-enabling clinical trials investigating adagrasib in patients with KRAS G12C mutations

Small business, Evon Medics, LLC today announced that community engagement and social work consultant, Mr. George C. McFarland has joined the advisory board of the company in a formal advisory role.

Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced that the Company’s Chief Executive Officer, Bill Enright, will be presenting at the Jefferies Virtual Healthcare Conference on Thursday, June 3 at 11:00 AM EDT.

Global Blood Therapeutics, Inc. announced that it will participate in a virtual fireside chat at the 42nd Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 8, 2021, at 2:10 p.m. Eastern Time.

Palmetto GBA, Administrator of Medicare in Seven States, Publishes Draft Local Coverage Determination